These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 3702443)
1. Metabolism of 4-hydroxyandrost-4-ene-3,17-dione by rat hepatocytes. Foster AB; Jarman M; Mann J; Parr IB J Steroid Biochem; 1986 Feb; 24(2):607-17. PubMed ID: 3702443 [TBL] [Abstract][Full Text] [Related]
2. Metabolism of the aromatase inhibitor 4-hydroxyandrostenedione in vivo. Identification of the glucuronide as a major urinary metabolite in patients and biliary metabolite in the rat. Goss PE; Jarman M; Wilkinson JR; Coombes RC J Steroid Biochem; 1986 Feb; 24(2):619-22. PubMed ID: 3509953 [TBL] [Abstract][Full Text] [Related]
3. Investigation of conjugated metabolites of 4-hydroxyandrost-4-ene-3,17-dione in patient urine by liquid chromatography-atmospheric pressure ionization mass spectrometry. Poon GK; Chui YC; Jarman M; Rowlands MG; Kokkonen PS; Niessen WM; van der Greef J Drug Metab Dispos; 1992; 20(6):941-7. PubMed ID: 1362950 [TBL] [Abstract][Full Text] [Related]
4. Multiple sites of steroid hydroxylation by the liver microsomal cytochrome P-450 system: primary and secondary metabolism of androstenedione. Sheets JJ; Estabrook RW Biochemistry; 1985 Nov; 24(23):6591-7. PubMed ID: 4084542 [TBL] [Abstract][Full Text] [Related]
5. Determination of 4-hydroxyandrost-4-ene-3,17-dione metabolism in breast cancer patients using high-performance liquid chromatography-mass spectrometry. Poon GK; Jarman M; Rowlands MG; Dowsett M; Firth J J Chromatogr; 1991 Apr; 565(1-2):75-88. PubMed ID: 1874906 [TBL] [Abstract][Full Text] [Related]
6. Selective 19-hydroxylase inhibition by an aromatase inhibitor, 4-hydroxyandrostenedione. Griffing GT; Holbrook M; Melby JC; Brodie AH Clin Physiol Biochem; 1988; 6(3-4):171-8. PubMed ID: 3203487 [TBL] [Abstract][Full Text] [Related]
7. Dissociation of 19-hydroxy- 19-oxo-, and aromatizing-activities in human placental microsomes through the use of suicide substrates to aromatase. Bednarski PJ; Nelson SD J Steroid Biochem; 1989 Feb; 32(2):309-16. PubMed ID: 2921872 [TBL] [Abstract][Full Text] [Related]
8. Effect of 4-hydroxyandrost-4-ene-3,17-dione (formestane) on the bile secretion and metabolism of 4-(14)C-cholesterol to bile acids. Czerny B; Teister M; Juzyszyn Z; Modrzejewski A; Pawlik A Pharmacol Rep; 2005; 57(6):896-900. PubMed ID: 16382215 [TBL] [Abstract][Full Text] [Related]
9. Synthesis of deuterium- and tritium-labelled 4-hydroxyandrostene-3,17-dione, an aromatase inhibitor, and its metabolism in vitro and in vivo in the rat. Marsh DA; Romanoff L; Williams KI; Brodie HJ; Brodie AM Biochem Pharmacol; 1982 Mar; 31(5):701-5. PubMed ID: 7082338 [TBL] [Abstract][Full Text] [Related]
10. Hepatic microsomal metabolism of androst-4-ene-3,17-dione: relative importance of ring hydroxylation and aromatization in control and induced rat liver. Murray M; Cantrill E; Farrell GC J Steroid Biochem; 1988 Feb; 29(2):233-7. PubMed ID: 3347063 [TBL] [Abstract][Full Text] [Related]
11. Aromatase inhibitors. Synthesis and biological activity of androstenedione derivatives. Marsh DA; Brodie HJ; Garrett W; Tsai-Morris CH; Brodie AM J Med Chem; 1985 Jun; 28(6):788-95. PubMed ID: 4009601 [TBL] [Abstract][Full Text] [Related]
12. Identification of 4-hydroxyandrost-4-ene-3,17-dione metabolites in prostatic cancer patients by liquid chromatography-mass spectrometry. Poon GK; Jarman M; McCague R; Davies JH; Heeremans CE; van der Hoeven RA; Niessen WM; van der Greef J J Chromatogr; 1992 May; 576(2):235-44. PubMed ID: 1400711 [TBL] [Abstract][Full Text] [Related]
13. Interactions of thiol-containing androgens with human placental aromatase. Bednarski PJ; Nelson SD J Med Chem; 1989 Jan; 32(1):203-13. PubMed ID: 2909733 [TBL] [Abstract][Full Text] [Related]
14. Metabolic studies of formestane in horses. Leung GN; Kwok WH; Wan TS; Lam KK; Schiff PJ Drug Test Anal; 2013 Jun; 5(6):412-9. PubMed ID: 23339113 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and bioconversions of formestane. Martin GD; Narvaez J; Marti A J Nat Prod; 2013 Oct; 76(10):1966-9. PubMed ID: 24074257 [TBL] [Abstract][Full Text] [Related]
16. Aromatase-inhibitors of the androstenedione-type activate the 17 beta-hydroxysteroid-dehydrogenase in the rat testis tissue suspension model. Schröder H; Ziegler M; el Etreby MF J Steroid Biochem; 1988 Oct; 31(4B):685-90. PubMed ID: 3199812 [TBL] [Abstract][Full Text] [Related]
17. Effect of 1,4,6-androstatriene-3,17-dione (ATD), 4-hydroxy-4-androstene-3,17-dione (4-OH-A) and 4-acetoxy-4-androstene-3,17-dione (4-Ac-A) on the 5 alpha-reduction of androgens in the rat prostate. Motta M; Zoppi S; Brodie AM; Martini L J Steroid Biochem; 1986 Oct; 25(4):593-600. PubMed ID: 3773531 [TBL] [Abstract][Full Text] [Related]
18. Metabolism of the steroidal aromatase inhibitor atamestane in rats, cynomolgus monkeys and humans. Isolation and identification of the major metabolites. Kuhnz W; Hoyer GA; Backhus S; Jakobs U Eur J Drug Metab Pharmacokinet; 1994; 19(2):137-50. PubMed ID: 8001594 [TBL] [Abstract][Full Text] [Related]
19. Hydroxylation of testosterone at carbons 1, 2, 6, 7, 15 and 16 by the hepatic microsomal fraction from adult female C57BL/6J mice. Ford HC; Wheeler R; Engel LL Eur J Biochem; 1975 Sep; 57(1):9-14. PubMed ID: 1175644 [TBL] [Abstract][Full Text] [Related]
20. Comparison of trans-stilbene oxide, phenobarbital and 3-methylcholanthrene as inducers of steroid metabolism by the rat liver microsomal cytochrome P-450 system. Meijer J; DePierre JW J Steroid Biochem; 1983 Apr; 18(4):425-35. PubMed ID: 6834827 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]